List of works - Anna Falanga

A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2.

scientific article published in March 2018

A Validated Risk Score for Venous Thromboembolism Is Predictive of Cancer Progression and Mortality

scientific article published on 28 April 2016

A cathepsin-like cysteine proteinase proaggregating activity in thrombotic thrombocytopenic purpura ⬇️

scientific article published on November 1, 1991

ADP-induced platelet aggregation and thrombin generation are increased in Essential Thrombocythemia and Polycythemia Vera

scientific article published on 2 June 2013

ASPIRIN INHIBITS PLATELET AGGREGATION BUT NOT BECAUSE IT PREVENTS THROMBOXANE SYNTHESIS

scientific article published in The Lancet

Activated prothrombin complex concentrate (FEIBA® ) in acquired haemophilia A: a large multicentre Italian study - the FAIR Registry

scientific article published on 12 March 2018

Activation of clotting factors in cancer.

scientific article published on January 2009

Acute promyelocytic leukemia cell adhesion to vascular endothelium is reduced by heparins

scientific article published on 01 May 2018

Addressing and proposing solutions for unmet clinical needs in the management of myeloproliferative neoplasm-associated thrombosis: A consensus-based position paper

scientific article published on 08 August 2019

All trans-retinoic acid modulates the procoagulant activity of human breast cancer cells ⬇️

scientific article published on April 1, 2011

All-trans-retinoic acid and bleeding/thrombosis.

scientific article published in January 2003

All-trans-retinoic acid increases adhesion to endothelium of the human promyelocytic leukaemia cell line NB4.

scientific article published on May 1996

American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.

scientific article published on 29 October 2007

Anticancer treatment and thrombosis.

scientific article

Anticoagulants and cancer survival.

scientific article published on November 2006

Antithrombotic medication in cancer-associated thrombocytopenia: Current evidence and knowledge gaps

scientific article published on 29 September 2018

Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide

scientific article published on 11 August 2011

Biological and clinical aspects of anticancer effects of antithrombotics.

scientific article

Bleeding and thrombosis in acute leukemia: what does the future of therapy look like?

scientific article

Blood coagulation changes in nude mice bearing human colon carcinomas

scientific article published on 01 January 1992

Blood oxidative status and selectins plasma levels in healthy donors receiving granulocyte-colony stimulating factor

scientific article published on 15 June 2006

Cancer Tissue Procoagulant Mechanisms and the Hypercoagulable State of Patients with Cancer

scientific article published on 26 September 2015

Cancer and venous thromboembolism

scientific article published on 01 October 2006

Cancer and venous thromboembolism.

scientific article

Cancer procoagulant in acute lymphoblastic leukemia

scientific article published on 01 August 1990

Cancer, thrombosis and heparin-induced thrombocytopenia

scientific article

Catastrophic relapse of Evans syndrome five years after allogeneic BMT notwithstanding full donor chimerism. Terminal hemolytic-uremic syndrome.

scientific article

Characterization of the thrombin generation potential of leukemic and solid tumor cells by calibrated automated thrombography

scientific article

Coagulation and cancer: biological and clinical aspects ⬇️

scientific article published on February 1, 2013

Comparison of properties of cancer procoagulant and human amnion-chorion procoagulant

scientific article published on 01 September 1985

Defibrotide reduces procoagulant activity and increases fibrinolytic properties of endothelial cells

scientific article published on 01 August 2003

Defining the thrombotic risk in patients with myeloproliferative neoplasms.

scientific article

Disseminated Intravascular Coagulation in Acute Leukemia ⬇️

scientific article published on December 1, 2001

Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer

scientific article published on April 1994

Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia

scientific article published on 08 June 2009

Epidemiology, risk and outcomes of venous thromboembolism in cancer

scientific article published on 05 October 2011

Eradication of acquired hemophilia associated with indolent non-Hodgkin lymphoma by a disease specific treatment

scientific article published on 4 March 2015

Evaluation of nucleated red blood cell count by Sysmex XE-2100 in patients with thalassaemia or sickle cell anaemia and in neonates

scientific article

Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trial

scientific article published on 01 June 2004

External validation of the DASH prediction rule: a retrospective cohort study.

scientific article published in August 2017

FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor

scientific article

Further characterization of platelet-aggregating cysteine proteinase activity in thrombotic thrombocytopenic purpura.

scientific article

Hemostatic biomarkers in cancer progression.

scientific article published in April 2018

Hemostatic complications of angiogenesis inhibitors in cancer patients.

scientific article

Hemostatic system activation in patients with lupus anticoagulant and essential thrombocythemia

scientific article published on 01 January 1994

Heparin in tumor progression and metastatic dissemination.

scientific article published on October 2007

Heparins inhibit the endothelial pro-thrombotic features induced by tumor cells.

scientific article

Human breast and colon carcinomas express cysteine proteinase activities with pro-aggregating and pro-coagulant properties

scientific article published on 01 October 1988

Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study

scientific article

Inefficacy of intravenous immunoglobulin in patients with low-risk thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome.

scientific article

Inhibition of cancer procoagulant by peptidyl diazomethyl ketones and peptidyl sulfonium salts.

scientific article

International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.

scientific article

Intravenous gammaglobulin, antiphospholipid antibodies, and thrombocytopenia

scientific article published on 01 October 1988

Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue.

scientific article

Italian daily platelet transfusion practice for haematological patients undergoing high dose chemotherapy with or without stem cell transplantation: a survey by the GIMEMA Haemostasis and Thrombosis Working Party.

scientific article published on 24 May 2016

Italian intersociety consensus on DOAC use in internal medicine

scientific article published on 13 February 2017

JAK2V617F mutation and hydroxyurea treatment as determinants of immature platelet parameters in essential thrombocythemia and polycythemia vera patients.

scientific article

LMWH bemiparin and ULMWH RO-14 reduce the endothelial angiogenic features elicited by leukemia, lung cancer, or breast cancer cells.

scientific article published on February 2011

Long Term Low Molecular Weight Heparin Anticoagulant Therapy Modulates Thrombin Generation and D-dimer in Patients with Cancer and Venous Thromboembolism.

scientific article published on 10 July 2017

Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study

scientific article published on 01 July 2012

Low levels of ADAMTS-13 with high anti-ADAMTS-13 antibodies during remission of immune-mediated thrombotic thrombocytopenic purpura highly predict for disease relapse: a multi-Institutional study

scientific article published on 29 April 2020

Management of Thrombohemorrhagic Syndromes (THS) in hematologic malignancies

scientific article

Management of cancer-associated disseminated intravascular coagulation: guidance from the SSC of the ISTH.

scientific article

Management of cancer-associated disseminated intravascular coagulation: guidance from the SSC of the ISTH: reply

scientific article published on 30 April 2015

Management of venous thromboembolism in cancer patients: ESMO clinical recommendations

scientific article published on 01 May 2008

Management of venous thromboembolism in cancer patients: ESMO clinical recommendations.

scientific article published on May 2009

Managing reversal of direct oral anticoagulants in emergency situations. Anticoagulation Education Task Force White Paper.

scientific article published on 4 August 2016

Mechanisms and risk factors of thrombosis in cancer

scientific article published on 25 August 2017

Mechanisms of thrombosis in cancer.

scientific article published on January 2013

Meeting Report EuroG20 Meeting on Cancer-Associated Thrombosis (CAT) Bergamo, Italy 7 April 2016.

scientific article

Microparticles in tumor progression.

scientific article published on April 2012

Molecular biomarkers of thrombosis in myeloproliferative neoplasms

scientific article published on April 2016

Monitoring thrombin generation: is addition of corn trypsin inhibitor needed?

scientific article published on 01 June 2009

Myeloproliferative neoplasms and thrombosis.

scientific article published on 03 July 2013

Nitric oxide derivatives and soluble plasma selectins in patients with myeloproliferative neoplasms.

scientific article published on 29 April 2010

Overview of the postulated mechanisms linking cancer and thrombosis

scientific article published on January 2008

PALB2 sequencing in Italian familial breast cancer cases reveals a high-risk mutation recurrent in the province of Bergamo

article

PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma.

scientific article published in September 2010

Pathogenesis and management of the bleeding diathesis in acute promyelocytic leukaemia.

scientific article

Pathogenesis and treatment of thrombohemorrhagic diathesis in acute promyelocytic leukemia.

scientific article published on 21 December 2011

Pathogenesis of thrombosis in patients with malignancy.

scientific article

Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results ⬇️

scientific article published on October 1, 2012

Phospholipid-dependent procoagulant activity is highly expressed by circulating microparticles in patients with essential thrombocythemia

scientific article

Platelet haemostatic properties in β-thalassaemia: the effect of blood transfusion.

scientific article published on 4 October 2016

Platelet-induced thrombin generation by the calibrated automated thrombogram assay is increased in patients with essential thrombocythemia and polycythemia vera

scientific article published on 01 April 2011

Platelet-mediated proteolytic down regulation of the anticoagulant activity of protein S in individuals with haematological malignancies.

scientific article

Practical management of ibrutinib in the real life: Focus on atrial fibrillation and bleeding

scientific article published on 7 March 2018

Predicting APL lethal bleeding in the ATRA era.

scientific article published in March 2017

Preface

Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgery

scientific article published on 01 December 1993

Prevention of venous thromboembolism in patients with cancer: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)1 ⬇️

scientific article published on 02 October 2011

Procoagulant activity of mouse transformed cells: Different expression in freshly isolated or cultured cells

scientific article published on 01 December 1988

Procoagulant mechanisms in tumour cells.

scientific article published on March 2009

Prospective study of hemostatic alterations in children with acute lymphoblastic leukemia

scientific article published in May 2010

Questions and answers on the use of dabigatran and perspectives on the use of other new oral anticoagulants in patients with atrial fibrillation. A consensus document of the Italian Federation of Thrombosis Centers (FCSA)

scientific article published on 22 September 2011

Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosis.

scientific article published on 9 May 2015

Reply to T.H. Oo.

scientific article

Selection and assessment of patients treated with the novel oral anticoagulant drugs: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and

scientific article published in January 2013

Several murine metastasizing tumors possess a cysteine proteinase with cancer procoagulant characteristics

scientific article published on 01 June 1987

Summary and Conclusions

scientific article published on 01 January 2008

Supranormal antithrombin III levels induced by concentrate administration are ineffective in quenching thrombin generation in acute promyelocytic leukemia

scientific article published on 01 February 1993

Thalidomide and thrombosis in multiple myeloma.

scientific article published in March 2003

The Decanucleotide Insertion/Deletion Polymorphism in the Promoter Region of the Coagulation Factor VII Gene and the Risk of Familial Myocardial Infarction

article

The SAME-TT2R2 score predicts the quality of anticoagulation control in patients with acute VTE. A real-life inception cohort study

scientific article published on 28 January 2016

The coagulopathy of cancer

scientific article

The effect of anticoagulant drugs on cancer

scientific article published on 01 August 2004

The extension of disease is associated to an increased risk of venous thromboembolism (VTE) in patients with gastrointestinal (GI) carcinoma

scientific article published on 01 April 2006

The impact of perioperative transfusion of blood products on survival after pediatric liver transplantation

scientific article

The incidence and risk of venous thromboembolism associated with cancer and nonsurgical cancer treatment.

scientific article published on January 2009

The mechanisms of cancer-associated thrombosis.

scientific article published on 09 February 2015

The prevention and management of asparaginase-related venous thromboembolism in adults: Guidance from the SSC on Hemostasis and Malignancy of the ISTH

scientific article published on 01 February 2020

Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia vera

scientific article published on 3 September 2008

Thrombophilic status may predict prognosis in patients with metastatic BRAFV600-mutated melanoma who are receiving BRAF inhibitors.

scientific article published in June 2016

Thrombosis and cancer: emerging data for the practicing oncologist.

scientific article

Thrombosis associated with angiogenesis inhibitors.

scientific article published on March 2009

Tissue Factor Expression on Platelet Surface during Preparation and Storage of Platelet Concentrates ⬇️

scientific article published on March 15, 2013

Treatment of venous thromboembolism in patients with cancer: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET).

scientific article published on 09 September 2009

V617F JAK-2 mutation in patients with essential thrombocythemia: relation to platelet, granulocyte, and plasma hemostatic and inflammatory molecules

scientific article published on 01 May 2007

Venous thromboembolism and cancer: guidelines of the Italian Association of Medical Oncology (AIOM).

scientific article published on 11 July 2006

Venous thromboembolism in the hematologic malignancies.

scientific article published on 14 September 2009

Venous thromboembolism prophylaxis and treatment in cancer: a consensus statement of major guidelines panels and call to action

scientific article

Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update

scientific article published on 14 April 2015

Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014.

scientific article published on 20 January 2015

Video meliora proboque sed deteriora sequor: the case of thromboprophylaxis in hospitalized cancer patients.

scientific article

Vitamin K-Dependent Procoagulant in Cancer Cells: A Potential Target for the Antimetastatic Effect of Warfarin?

scientific article published on 01 January 1986

List of works by Anna Falanga

A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2.

A Validated Risk Score for Venous Thromboembolism Is Predictive of Cancer Progression and Mortality

A cathepsin-like cysteine proteinase proaggregating activity in thrombotic thrombocytopenic purpura ⬇️

ADP-induced platelet aggregation and thrombin generation are increased in Essential Thrombocythemia and Polycythemia Vera

ASPIRIN INHIBITS PLATELET AGGREGATION BUT NOT BECAUSE IT PREVENTS THROMBOXANE SYNTHESIS

Activated prothrombin complex concentrate (FEIBA® ) in acquired haemophilia A: a large multicentre Italian study - the FAIR Registry

Activation of clotting factors in cancer.

Acute promyelocytic leukemia cell adhesion to vascular endothelium is reduced by heparins

Addressing and proposing solutions for unmet clinical needs in the management of myeloproliferative neoplasm-associated thrombosis: A consensus-based position paper

All trans-retinoic acid modulates the procoagulant activity of human breast cancer cells ⬇️

All-trans-retinoic acid and bleeding/thrombosis.

All-trans-retinoic acid increases adhesion to endothelium of the human promyelocytic leukaemia cell line NB4.

American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.

Anticancer treatment and thrombosis.

Anticoagulants and cancer survival.

Antithrombotic medication in cancer-associated thrombocytopenia: Current evidence and knowledge gaps

Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide

Biological and clinical aspects of anticancer effects of antithrombotics.

Bleeding and thrombosis in acute leukemia: what does the future of therapy look like?

Blood coagulation changes in nude mice bearing human colon carcinomas

Blood oxidative status and selectins plasma levels in healthy donors receiving granulocyte-colony stimulating factor

Cancer Tissue Procoagulant Mechanisms and the Hypercoagulable State of Patients with Cancer

Cancer and venous thromboembolism

Cancer and venous thromboembolism.

Cancer procoagulant in acute lymphoblastic leukemia

Cancer, thrombosis and heparin-induced thrombocytopenia

Catastrophic relapse of Evans syndrome five years after allogeneic BMT notwithstanding full donor chimerism. Terminal hemolytic-uremic syndrome.

Characterization of the thrombin generation potential of leukemic and solid tumor cells by calibrated automated thrombography

Coagulation and cancer: biological and clinical aspects ⬇️

Comparison of properties of cancer procoagulant and human amnion-chorion procoagulant

Defibrotide reduces procoagulant activity and increases fibrinolytic properties of endothelial cells

Defining the thrombotic risk in patients with myeloproliferative neoplasms.

Disseminated Intravascular Coagulation in Acute Leukemia ⬇️

Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer

Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia

Epidemiology, risk and outcomes of venous thromboembolism in cancer

Eradication of acquired hemophilia associated with indolent non-Hodgkin lymphoma by a disease specific treatment

Evaluation of nucleated red blood cell count by Sysmex XE-2100 in patients with thalassaemia or sickle cell anaemia and in neonates

Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trial

External validation of the DASH prediction rule: a retrospective cohort study.

FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor

Further characterization of platelet-aggregating cysteine proteinase activity in thrombotic thrombocytopenic purpura.

Hemostatic biomarkers in cancer progression.

Hemostatic complications of angiogenesis inhibitors in cancer patients.

Hemostatic system activation in patients with lupus anticoagulant and essential thrombocythemia

Heparin in tumor progression and metastatic dissemination.

Heparins inhibit the endothelial pro-thrombotic features induced by tumor cells.

Human breast and colon carcinomas express cysteine proteinase activities with pro-aggregating and pro-coagulant properties

Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study

Inefficacy of intravenous immunoglobulin in patients with low-risk thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome.

Inhibition of cancer procoagulant by peptidyl diazomethyl ketones and peptidyl sulfonium salts.

International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.

Intravenous gammaglobulin, antiphospholipid antibodies, and thrombocytopenia

Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue.

Italian daily platelet transfusion practice for haematological patients undergoing high dose chemotherapy with or without stem cell transplantation: a survey by the GIMEMA Haemostasis and Thrombosis Working Party.

Italian intersociety consensus on DOAC use in internal medicine

JAK2V617F mutation and hydroxyurea treatment as determinants of immature platelet parameters in essential thrombocythemia and polycythemia vera patients.

LMWH bemiparin and ULMWH RO-14 reduce the endothelial angiogenic features elicited by leukemia, lung cancer, or breast cancer cells.

Long Term Low Molecular Weight Heparin Anticoagulant Therapy Modulates Thrombin Generation and D-dimer in Patients with Cancer and Venous Thromboembolism.

Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study

Low levels of ADAMTS-13 with high anti-ADAMTS-13 antibodies during remission of immune-mediated thrombotic thrombocytopenic purpura highly predict for disease relapse: a multi-Institutional study

Management of Thrombohemorrhagic Syndromes (THS) in hematologic malignancies

Management of cancer-associated disseminated intravascular coagulation: guidance from the SSC of the ISTH.

Management of cancer-associated disseminated intravascular coagulation: guidance from the SSC of the ISTH: reply

Management of venous thromboembolism in cancer patients: ESMO clinical recommendations

Management of venous thromboembolism in cancer patients: ESMO clinical recommendations.

Managing reversal of direct oral anticoagulants in emergency situations. Anticoagulation Education Task Force White Paper.

Mechanisms and risk factors of thrombosis in cancer

Mechanisms of thrombosis in cancer.

Meeting Report EuroG20 Meeting on Cancer-Associated Thrombosis (CAT) Bergamo, Italy 7 April 2016.

Microparticles in tumor progression.

Molecular biomarkers of thrombosis in myeloproliferative neoplasms

Monitoring thrombin generation: is addition of corn trypsin inhibitor needed?

Myeloproliferative neoplasms and thrombosis.

Nitric oxide derivatives and soluble plasma selectins in patients with myeloproliferative neoplasms.

Overview of the postulated mechanisms linking cancer and thrombosis

PALB2 sequencing in Italian familial breast cancer cases reveals a high-risk mutation recurrent in the province of Bergamo

PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma.

Pathogenesis and management of the bleeding diathesis in acute promyelocytic leukaemia.